In The Name Of God Introduction to Dermatopathologic

Slides:



Advertisements
Similar presentations
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Advertisements

Amy Y-Y Chen, MD Andrew Chen, MD
Well differentiated squamous cell carcinoma, keratoacanthoma type (Keratoacanthoma): Three cases Deba P Sarma, MD Omaha.
Polymorphism & Restriction Fragment Length Polymorphism (RFLP)
Research Techniques Made Simple: T-Cell Receptor Gene Rearrangement
Signs, Symptoms and Findings. EXAMPLES OF TYPES OF PHYSICAL PATHOLOGY Independent organismal continuant Portion of canonical body substance Pathological.
INTRODUCTION BASIS FOR CLINICAL DIFFERENTIAL DIAGNOSIS Dr.Shahzadi Tayyaba Hashmi DNT 243.
Case Study 62 Kenneth Clark, MD. Question 1 This is a 32-year-old woman with progressive distortion of taste and smell. After seeing her primary care.
The Complete Diagnosis Coding Book by Shelley C. Safian, MAOM/HSM, CCS-P, CPC-H, CHA Chapter 5 Coding Neoplasms Copyright © 2009 by The McGraw-Hill Companies,
Fluorescent In Situ Hybridization (FISH) to Identify Genetic Changes in Fine Needle Biopsy of Lung Lesions Prepared by Jin Jen NCI.
Dermatopathology.
Diseases of the Pancreas November 19, 2007 NCDD Meeting Chair: Jane Holt Vice Chair: P. Jay Pasricha, MD.
Rare mammary gland diseases: a continuous challenge for the clinician
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
WORK UP & MANAGEMENT OF SOLITARY PULMONARY NODULE Seifu B Oct-04, 2007.
Tumors Dr. N. Salmo. Adrenal cortical tumor. Describe it grossly. Benign or Malignant??
FISHing for tricky naevi Dr Hardeep Singh Manchester BAOP 2011.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
Dr. Saleem Shaikh NEOPLASIA - II. Majority of the neoplasms are categorised clinically and morphologically into benign and malignant on basis of certain.
INTRODUCTION BASIS FOR CLINICAL DIFFERENTIAL DIAGNOSIS Dr. Shahzadi Tayyaba Hashmi
NODULAR MELANOCYTIC NEVI IN THE FIBROUS CAPSULE OF AXILLARY LYMPH NODE. REPORT OF A CASE. F. Tallarigo, I. Putrino, A.V. Filardo°, S. Squillaci°° Anatomia.
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Dr. Usha Sarma, Asstt. Professor, Dr. U. C. Dutta, Prof & Head, Pathology Deptt Gauhati Medical College FNAC of Thyroid Lesion 5 Years retrospective study.
Course Coordinator Dr Sami Fathi MBBS,MSc,MD
Psoriasis and Other Papulosquamous Disease
Woo Cheal Cho MD1, Fabiola Balarezo, MD1
Primitive Ano-rectal area melanoma:Case Report
Clear cell acanthoma or Degos' acanthoma
Figure 4. Histologic, immunohistochemical analyses of inflammatory myofibroblastic tumor (IMT) at metastasis diagnosis after complete surgical resection.
Blue nevus and cellular blue nevusA
Department of Laboratory Medicine, CORE Diagnostics, Gurgaon, India
Radiologic Features of Inflammatory Pseudotumor of the Ureter
Introduction to Pathology DR:Gehan mohamed
Subcellular Localization of NEDD9 and HMB45 with AQUA Technology to Distinguish Spitz Nevi from Melanomas Matthew C. McRae MD, MHS 1; Rossitza Lasova MD.
Investigation strategies and methods
Dr Amit Gupta Associate Professor Dept of Surgery
Chapter 12 Liver Transplantation 1
How do we delay disease progress once it has started?
Expression of Endomucin, a Novel Endothelial Sialomucin, in Normal and Diseased Human Skin  Annegret Kuhn, MD, Gertrud Brachtendorf, Frank Kurth, Monika.
Pigmented Lesions.
Phrasing of pathology report
Molecular Diagnosis of Clear Cell Sarcoma
Adrian G. Sacher, MD, Kimberly M. Komatsubara, MD, Geoffrey R
Why Seborrheic Keratosis Should Be on Your Radar
Focus on endometrial and cervical cancer
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky
SOFT TISSUE & SKELETAL SYSTEM LABORATORY
Molecular Diagnosis in Ewing Family Tumors
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
(وفى الأرض آيات للموقنين وفى أنفسكم أفلا تبصرون )
M. J. Röβler, G. Rappl, M. Muche, D. O. Hasselmann, W. Sterry, W
Cybele Fishman, MD, Martin C Mihm, MD, Arthur J Sober, MD 
Handling and Evaluation of Breast Cancer Biopsy
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
Molecular Aspects of Melanocytic Dysplastic Nevi
Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases  Alan S. Boyd, MD, Bashar Shakhtour,
Case Study 35 Henry Armah, M.D., M.Phil..
Sven Seiwerth UZSM and KBC Zagreb Zagreb, Croatia
JAMA Ophthalmology Journal Club Slides: Clinical Features of Benign vs Malignant Conjunctival Tumors in Children Shields CL, Sioufi K, Alset AE, et al.
Selective Expression of FLIP in Malignant Melanocytic Skin Lesions
Regine Keller-Melchior, Rodney Schmidt, Michael Piepkorn 
Talk outline Brief history of gene-expression profiling for cancer type classification Current commercially available tests - development and performance.
Primary paediatric cutaneous mucinoses
Dermatoscopic description of non-infectious balanitis
No Evidence of Human Herpesvirus 8 Infection in Patients with Paraneoplastic Pemphigus, Pemphigus Vulgaris, or Pemphigus Foliaceus  Sandra S. Cohen, Andrew.
Diagnostic testing for identification of the microbiological etiology of infective endocarditis. Diagnostic testing for identification of the microbiological.
Marián Švajdler UNLP Košice
Presentation transcript:

In The Name Of God Introduction to Dermatopathologic By: Dr Marhamati

Histopathology : gold standard for most dermatologic diagnoses but not all lesions are amenable to definitive (specific) histologic diagnosis. SPECIFICITY = True Negative Rate SENSITIVITY = True Positive Rate

Most melanoma are positive for S100(high sensitivity) All benign melanocytic neoplasms are positive for S100(low specificity) Frequent mitoses are common in bulky melanoma,but rare in most benign melanocytic neoplasms(relatively specific but non pathognomic marker for melanoma) Mitotic figures are absent in most thin nontumorigenic melanoma(low sensitivity) HMB45 antibody found in: Melanoma,blue nevus and other benign lesions

Ultrastructural, immunohistochemical, and molecular test :increased specificity for many diagnoses Immunofluorescence used to differentiate among vesiculobullous disorders. Fusion transctipt for EWS-ATF1 detected by RT-PCR or FISH used to distinguish between primary clear cell sarcoma and a malignant melanoma

Morphology is still the basis of diagnosis for most neoplasms and inflammatory dermatoses. Follow-up studies of outcome: gold standard for validation of diagnostic utility

Histologic picture of many inflammatory dermatoses is more typically “ Compatible with” or suggestive, rather than “Diagnostic of” clinical process. For example: papulosquamous dermatoses, such as psoriasis or lichen planus.

Histopathology can ruling out an important diagnosis( even though an exact diagnosis cannot be made) For example: review of a biopsy of a psoriasiform plaque may rule out mycosis fungoides , but may not be able to establish the specific diagnosis of psoriasis.

Diagnostic limitations of histology in :infectious and neoplastic processes For example, infectious granulomas of different etiologies are not readily distinguishable, unless the causative organism can be demonstrated.(with more sensitive staining for organism as Grocott or acid-fast ) PCR test for foreign DNA diagnostic for infectious agent.

Histology may not suffice to distinguish between keratoacanthoma and SCC, or between Spitz nevus and melanoma Comparative genomic hybridization Or FISH differentiated between spitz nevus and melanoma

Improving diagnostic specificity will be achieved by: Correlation between molecular, histologic, gross anatomic levels with the physical findings and clinical history, interpreted in the context of the whole patient and his or her environment, with long-term follow-up serving as the “Gold standard”. Tumors of uncertain malignant potential tailored with worst- case scenario